Hyro Secures Series B Extension

by Kay Aloha Villamor in December 11th, 2024

Hyro, a New York-based provider of AI-powered voice and chat solutions for healthcare, has secured a Series B funding extension. 

Investors 

The round was led by Healthier Capital, which joined previous investors, including Macquarie Capital, Liberty Mutual, Twilio Inc., and Black Opal Ventures, bringing the company’s total funding to $50M. 

Healthier Capital’s founder, Amir Dan Rubin, former CEO of One Medical, will join Hyro’s board. 

Hyro Use of Funds 

This funding will help Hyro meet the growing demand for responsible AI agents in healthcare. The company plans to expand its solutions in 2025, including preventing appointment no-shows and enhancing its AI analytics suite. 

About Hyro 

Founded in 2018 by Israel Krush and Rom Cohen, Hyro provides a responsible AI-powered communications platform for healthcare designed to improve patient engagement by automating routine interactions such as appointment scheduling, registration, IT helpdesk, and prescription refills. The platform leverages conversational technologies, including large language models (LLMs), and integrates with existing healthcare systems, offering HIPAA-compliant, secure, and efficient communication tools. 

Funding Details 

Company: Hyro AI Inc. 

Raised: Undisclosed 

Round: Series B Extension 

Funding Date: December 2024 

Lead Investor: Healthier Capital 

Additional Investors: Macquarie Capital, Liberty Mutual, Twilio Inc., Black Opal Ventures 

Company Website: https://www.hyro.ai/  

Software Category: Healthcare Solutions 

Source: https://www.prnewswire.com/news-releases/healthier-capital-led-by-former-one-medical-ceo-invests-in-hyros-responsible-ai-agents-for-healthcare-302327079.html 

Your cart